We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO icon
3101
Bio-Rad Laboratories Class A
BIO
$9.42B
$7K ﹤0.01%
+46
New +$6.56K
BBBY
3102
Bed Bath & Beyond
BBBY
$442M
$7K ﹤0.01%
576
+255
+79% +$3.04K
CASS icon
3103
Cass Information Systems
CASS
$743M
$7K ﹤0.01%
162
+31
+24% +$1.16K
CBZ icon
3104
CBIZ
CBZ
$2.96B
$7K ﹤0.01%
635
+198
+45% +$2.04K
CEE
3105
Central and Eastern Europe Fund
CEE
$139M
$7K ﹤0.01%
+384
New +$7.1K
CERS icon
3106
Cerus
CERS
$474M
$7K ﹤0.01%
1,158
+862
+291% +$5.13K
CSPI icon
3107
CSP Inc
CSPI
$82.1M
$7K ﹤0.01%
1,768
+658
+59% +$2.38K
CTO
3108
CTO Realty Growth
CTO
$815M
$7K ﹤0.01%
516
-431
-46% -$5.61K
CULP icon
3109
Culp Inc
CULP
$44.1M
$7K ﹤0.01%
+240
New +$6.54K
CVLG icon
3110
Covenant Logistics
CVLG
$872M
$7K ﹤0.01%
+866
New +$9.21K
CYTK icon
3111
Cytokinetics
CYTK
$10.4B
$7K ﹤0.01%
716
-564
-44% -$4.63K
DAC icon
3112
Danaos Corp
DAC
$2.56B
$7K ﹤0.01%
175
+56
+47% +$2.76K
DBVT
3113
DBV Technologies
DBVT
$847M
$7K ﹤0.01%
22
+12
+120% +$3.89K
DNOW icon
3114
DNOW Inc
DNOW
$2.99B
$7K ﹤0.01%
403
-4,565
-92% -$80.1K
EDEN icon
3115
iShares MSCI Denmark ETF
EDEN
$206M
$7K ﹤0.01%
121
+20
+20% +$1.13K
EG icon
3116
Everest Group
EG
$14.4B
$7K ﹤0.01%
+37
New +$6.8K
ENTA icon
3117
Enanta Pharmaceuticals
ENTA
$400M
$7K ﹤0.01%
300
+93
+45% +$2.43K
FANG icon
3118
Diamondback Energy
FANG
$52.7B
$7K ﹤0.01%
75
-1,111
-94% -$96K
FCAP icon
3119
First Capital
FCAP
$214M
$7K ﹤0.01%
221
-64
-22% -$1.97K
FCVT icon
3120
First Trust SSI Strategic Convertible Securities ETF
FCVT
$101M
$7K ﹤0.01%
300
+292
+3,650% +$7.23K
FN icon
3121
Fabrinet
FN
$20.1B
$7K ﹤0.01%
196
+88
+81% +$3.01K
FNK icon
3122
First Trust Mid Cap Value AlphaDEX Fund
FNK
$231M
$7K ﹤0.01%
+268
New +$7.57K
GBDC icon
3123
Golub Capital BDC
GBDC
$3.42B
$7K ﹤0.01%
394
-97
-20% -$1.65K
GHM icon
3124
Graham Corp
GHM
$1.31B
$7K ﹤0.01%
+360
New +$6.64K
GNSS icon
3125
Genasys
GNSS
$79.2M
$7K ﹤0.01%
4,111
+4,010
+3,970% +$7.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.